{"disease":{"id":"hypervascular-tumors","name":"hypervascular tumors"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04523350","title":"Instylla HES Hypervascular Tumor Pivotal Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Instylla, Inc.","has_results":false},{"nct_id":"NCT06170619","title":"Obsidio™ Conformable Embolic Registry","phase":"","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"Boston Scientific Corporation","has_results":false},{"nct_id":"NCT04272216","title":"An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres","phase":"","overall_status":"COMPLETED","enrollment_count":99,"lead_sponsor_name":"Terumo Medical Corporation","has_results":true}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}